Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD
Summary Fibroblast growth factor 23(FGF23) is a bone-derived hormone which regulates mineral homeostasis but may also have a role in cardiovascular disease. Here, we found that higher plasma FGF23 was independently associated with decreased heart rate variability in stage 5 CKD patients and parathyr...
Saved in:
| Published in: | Osteoporosis international Vol. 26; no. 1; pp. 395 - 405 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
Springer London
01.01.2015
Springer Nature B.V |
| Subjects: | |
| ISSN: | 0937-941X, 1433-2965, 1433-2965 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Summary
Fibroblast growth factor 23(FGF23) is a bone-derived hormone which regulates mineral homeostasis but may also have a role in cardiovascular disease. Here, we found that higher plasma FGF23 was independently associated with decreased heart rate variability in stage 5 CKD patients and parathyroidectomy may reverse these abnormal indicators.
Introduction
Lower heart rate variability (HRV) in patients with chronic kidney disease (CKD) compared with healthy controls is associated with increased risk of cardiovascular disease (CVD). Higher levels of plasma FGF23 also predict higher risk of CVD. Here, we aimed to evaluate the relationship between plasma FGF23 levels and HRV in patients with stage 5 CKD and to investigate longitudinal changes of them together with the correlation between their changes in two severe secondary hyperparathyroidism (SHPT) subgroups with successful parathyroidectomy (PTX) and persistent SHPT.
Methods
This cross-sectional study included 100 stage 5 CKD patients, 78 controls, and a prospective study in two PTX subgroups classified as successful PTX (
n
= 24) and persistent SHPT (
n
= 4) follow-up. Blood examination and 24-h Holter monitoring for HRV were measured.
Results
Most HRV indices were lower in stage 5 CKD patients than in healthy controls, and plasma FGF23 levels were higher. In multivariate stepwise regression models, levels of plasma FGF23 and serum parathyroid hormone (PTH) were correlated with HRV. The successful PTX subgroup had significant improvements over baseline in HRV indices. Persistent SHPT subgroup had numerically similar changes in HRV indices. However, plasma FGF23 levels decreased in both subgroups.
Conclusions
Plasma FGF23 levels were higher in CKD patients than in controls, much higher in patients with severe SHPT. FGF23 was independently associated with decreased HRV in stage 5 CKD. Successful PTX may reverse these abnormal indicators and contribute to decreases in the risk of cardiovascular disease. |
|---|---|
| AbstractList | Fibroblast growth factor 23(FGF23) is a bone-derived hormone which regulates mineral homeostasis but may also have a role in cardiovascular disease. Here, we found that higher plasma FGF23 was independently associated with decreased heart rate variability in stage 5 CKD patients and parathyroidectomy may reverse these abnormal indicators. Introduction: Lower heart rate variability (HRV) in patients with chronic kidney disease (CKD) compared with healthy controls is associated with increased risk of cardiovascular disease (CVD). Higher levels of plasma FGF23 also predict higher risk of CVD. Here, we aimed to evaluate the relationship between plasma FGF23 levels and HRV in patients with stage 5 CKD and to investigate longitudinal changes of them together with the correlation between their changes in two severe secondary hyperparathyroidism (SHPT) subgroups with successful parathyroidectomy (PTX) and persistent SHPT. Methods: This cross-sectional study included 100 stage 5 CKD patients, 78 controls, and a prospective study in two PTX subgroups classified as successful PTX (n=24) and persistent SHPT (n=4) follow-up. Blood examination and 24-h Holter monitoring for HRV were measured. Results: Most HRV indices were lower in stage 5 CKD patients than in healthy controls, and plasma FGF23 levels were higher. In multivariate stepwise regression models, levels of plasma FGF23 and serum parathyroid hormone (PTH) were correlated with HRV. The successful PTX subgroup had significant improvements over baseline in HRV indices. Persistent SHPT subgroup had numerically similar changes in HRV indices. However, plasma FGF23 levels decreased in both subgroups. Conclusions: Plasma FGF23 levels were higher in CKD patients than in controls, much higher in patients with severe SHPT. FGF23 was independently associated with decreased HRV in stage 5 CKD. Successful PTX may reverse these abnormal indicators and contribute to decreases in the risk of cardiovascular disease. Fibroblast growth factor 23(FGF23) is a bone-derived hormone which regulates mineral homeostasis but may also have a role in cardiovascular disease. Here, we found that higher plasma FGF23 was independently associated with decreased heart rate variability in stage 5 CKD patients and parathyroidectomy may reverse these abnormal indicators. Lower heart rate variability (HRV) in patients with chronic kidney disease (CKD) compared with healthy controls is associated with increased risk of cardiovascular disease (CVD). Higher levels of plasma FGF23 also predict higher risk of CVD. Here, we aimed to evaluate the relationship between plasma FGF23 levels and HRV in patients with stage 5 CKD and to investigate longitudinal changes of them together with the correlation between their changes in two severe secondary hyperparathyroidism (SHPT) subgroups with successful parathyroidectomy (PTX) and persistent SHPT. This cross-sectional study included 100 stage 5 CKD patients, 78 controls, and a prospective study in two PTX subgroups classified as successful PTX (n = 24) and persistent SHPT (n = 4) follow-up. Blood examination and 24-h Holter monitoring for HRV were measured. Most HRV indices were lower in stage 5 CKD patients than in healthy controls, and plasma FGF23 levels were higher. In multivariate stepwise regression models, levels of plasma FGF23 and serum parathyroid hormone (PTH) were correlated with HRV. The successful PTX subgroup had significant improvements over baseline in HRV indices. Persistent SHPT subgroup had numerically similar changes in HRV indices. However, plasma FGF23 levels decreased in both subgroups. Plasma FGF23 levels were higher in CKD patients than in controls, much higher in patients with severe SHPT. FGF23 was independently associated with decreased HRV in stage 5 CKD. Successful PTX may reverse these abnormal indicators and contribute to decreases in the risk of cardiovascular disease. Fibroblast growth factor 23(FGF23) is a bone-derived hormone which regulates mineral homeostasis but may also have a role in cardiovascular disease. Here, we found that higher plasma FGF23 was independently associated with decreased heart rate variability in stage 5 CKD patients and parathyroidectomy may reverse these abnormal indicators.UNLABELLEDFibroblast growth factor 23(FGF23) is a bone-derived hormone which regulates mineral homeostasis but may also have a role in cardiovascular disease. Here, we found that higher plasma FGF23 was independently associated with decreased heart rate variability in stage 5 CKD patients and parathyroidectomy may reverse these abnormal indicators.Lower heart rate variability (HRV) in patients with chronic kidney disease (CKD) compared with healthy controls is associated with increased risk of cardiovascular disease (CVD). Higher levels of plasma FGF23 also predict higher risk of CVD. Here, we aimed to evaluate the relationship between plasma FGF23 levels and HRV in patients with stage 5 CKD and to investigate longitudinal changes of them together with the correlation between their changes in two severe secondary hyperparathyroidism (SHPT) subgroups with successful parathyroidectomy (PTX) and persistent SHPT.INTRODUCTIONLower heart rate variability (HRV) in patients with chronic kidney disease (CKD) compared with healthy controls is associated with increased risk of cardiovascular disease (CVD). Higher levels of plasma FGF23 also predict higher risk of CVD. Here, we aimed to evaluate the relationship between plasma FGF23 levels and HRV in patients with stage 5 CKD and to investigate longitudinal changes of them together with the correlation between their changes in two severe secondary hyperparathyroidism (SHPT) subgroups with successful parathyroidectomy (PTX) and persistent SHPT.This cross-sectional study included 100 stage 5 CKD patients, 78 controls, and a prospective study in two PTX subgroups classified as successful PTX (n = 24) and persistent SHPT (n = 4) follow-up. Blood examination and 24-h Holter monitoring for HRV were measured.METHODSThis cross-sectional study included 100 stage 5 CKD patients, 78 controls, and a prospective study in two PTX subgroups classified as successful PTX (n = 24) and persistent SHPT (n = 4) follow-up. Blood examination and 24-h Holter monitoring for HRV were measured.Most HRV indices were lower in stage 5 CKD patients than in healthy controls, and plasma FGF23 levels were higher. In multivariate stepwise regression models, levels of plasma FGF23 and serum parathyroid hormone (PTH) were correlated with HRV. The successful PTX subgroup had significant improvements over baseline in HRV indices. Persistent SHPT subgroup had numerically similar changes in HRV indices. However, plasma FGF23 levels decreased in both subgroups.RESULTSMost HRV indices were lower in stage 5 CKD patients than in healthy controls, and plasma FGF23 levels were higher. In multivariate stepwise regression models, levels of plasma FGF23 and serum parathyroid hormone (PTH) were correlated with HRV. The successful PTX subgroup had significant improvements over baseline in HRV indices. Persistent SHPT subgroup had numerically similar changes in HRV indices. However, plasma FGF23 levels decreased in both subgroups.Plasma FGF23 levels were higher in CKD patients than in controls, much higher in patients with severe SHPT. FGF23 was independently associated with decreased HRV in stage 5 CKD. Successful PTX may reverse these abnormal indicators and contribute to decreases in the risk of cardiovascular disease.CONCLUSIONSPlasma FGF23 levels were higher in CKD patients than in controls, much higher in patients with severe SHPT. FGF23 was independently associated with decreased HRV in stage 5 CKD. Successful PTX may reverse these abnormal indicators and contribute to decreases in the risk of cardiovascular disease. Summary Fibroblast growth factor 23(FGF23) is a bone-derived hormone which regulates mineral homeostasis but may also have a role in cardiovascular disease. Here, we found that higher plasma FGF23 was independently associated with decreased heart rate variability in stage 5 CKD patients and parathyroidectomy may reverse these abnormal indicators. Introduction Lower heart rate variability (HRV) in patients with chronic kidney disease (CKD) compared with healthy controls is associated with increased risk of cardiovascular disease (CVD). Higher levels of plasma FGF23 also predict higher risk of CVD. Here, we aimed to evaluate the relationship between plasma FGF23 levels and HRV in patients with stage 5 CKD and to investigate longitudinal changes of them together with the correlation between their changes in two severe secondary hyperparathyroidism (SHPT) subgroups with successful parathyroidectomy (PTX) and persistent SHPT. Methods This cross-sectional study included 100 stage 5 CKD patients, 78 controls, and a prospective study in two PTX subgroups classified as successful PTX ( n = 24) and persistent SHPT ( n = 4) follow-up. Blood examination and 24-h Holter monitoring for HRV were measured. Results Most HRV indices were lower in stage 5 CKD patients than in healthy controls, and plasma FGF23 levels were higher. In multivariate stepwise regression models, levels of plasma FGF23 and serum parathyroid hormone (PTH) were correlated with HRV. The successful PTX subgroup had significant improvements over baseline in HRV indices. Persistent SHPT subgroup had numerically similar changes in HRV indices. However, plasma FGF23 levels decreased in both subgroups. Conclusions Plasma FGF23 levels were higher in CKD patients than in controls, much higher in patients with severe SHPT. FGF23 was independently associated with decreased HRV in stage 5 CKD. Successful PTX may reverse these abnormal indicators and contribute to decreases in the risk of cardiovascular disease. Fibroblast growth factor 23(FGF23) is a bone-derived hormone which regulates mineral homeostasis but may also have a role in cardiovascular disease. Here, we found that higher plasma FGF23 was independently associated with decreased heart rate variability in stage 5 CKD patients and parathyroidectomy may reverse these abnormal indicators. Lower heart rate variability (HRV) in patients with chronic kidney disease (CKD) compared with healthy controls is associated with increased risk of cardiovascular disease (CVD). Higher levels of plasma FGF23 also predict higher risk of CVD. Here, we aimed to evaluate the relationship between plasma FGF23 levels and HRV in patients with stage 5 CKD and to investigate longitudinal changes of them together with the correlation between their changes in two severe secondary hyperparathyroidism (SHPT) subgroups with successful parathyroidectomy (PTX) and persistent SHPT. This cross-sectional study included 100 stage 5 CKD patients, 78 controls, and a prospective study in two PTX subgroups classified as successful PTX (n=24) and persistent SHPT (n=4) follow-up. Blood examination and 24-h Holter monitoring for HRV were measured. Most HRV indices were lower in stage 5 CKD patients than in healthy controls, and plasma FGF23 levels were higher. In multivariate stepwise regression models, levels of plasma FGF23 and serum parathyroid hormone (PTH) were correlated with HRV. The successful PTX subgroup had significant improvements over baseline in HRV indices. Persistent SHPT subgroup had numerically similar changes in HRV indices. However, plasma FGF23 levels decreased in both subgroups. Plasma FGF23 levels were higher in CKD patients than in controls, much higher in patients with severe SHPT. FGF23 was independently associated with decreased HRV in stage 5 CKD. Successful PTX may reverse these abnormal indicators and contribute to decreases in the risk of cardiovascular disease.[PUBLICATION ABSTRACT] |
| Author | Cui, Y.-Y. Sun, B. Yang, G. Zhang, L.-N. Shen, Z.-X. Xing, C.-Y. Zhang, J.-J. Zeng, M. Wang, N.-N. Ge, Y.-F. Cheng, C. Ouyang, C. Zhang, B. Shen, C. Zha, X.-M. Liu, J. Yu, X.-B. Mao, H.-J. Zhang, J. |
| Author_xml | – sequence: 1 givenname: L.-N. surname: Zhang fullname: Zhang, L.-N. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 2 givenname: G. surname: Yang fullname: Yang, G. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 3 givenname: C. surname: Cheng fullname: Cheng, C. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 4 givenname: C. surname: Shen fullname: Shen, C. organization: Nanjing Medical University – sequence: 5 givenname: Y.-Y. surname: Cui fullname: Cui, Y.-Y. organization: Department of General Surgery, First Affiliated Hospital of Nanjing Medical University – sequence: 6 givenname: J. surname: Zhang fullname: Zhang, J. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 7 givenname: J.-J. surname: Zhang fullname: Zhang, J.-J. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 8 givenname: Z.-X. surname: Shen fullname: Shen, Z.-X. organization: Department of Nephrology, Jiangsu Province Geriatric Hospital – sequence: 9 givenname: M. surname: Zeng fullname: Zeng, M. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 10 givenname: Y.-F. surname: Ge fullname: Ge, Y.-F. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 11 givenname: B. surname: Sun fullname: Sun, B. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 12 givenname: X.-B. surname: Yu fullname: Yu, X.-B. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 13 givenname: C. surname: Ouyang fullname: Ouyang, C. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 14 givenname: B. surname: Zhang fullname: Zhang, B. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 15 givenname: H.-J. surname: Mao fullname: Mao, H.-J. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 16 givenname: J. surname: Liu fullname: Liu, J. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 17 givenname: C.-Y. surname: Xing fullname: Xing, C.-Y. organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University – sequence: 18 givenname: X.-M. surname: Zha fullname: Zha, X.-M. email: zhaxm@medmail.com organization: Department of General Surgery, First Affiliated Hospital of Nanjing Medical University – sequence: 19 givenname: N.-N. surname: Wang fullname: Wang, N.-N. email: wangnn@njmu.edu.cn organization: Department of Nephrology, First Affiliated Hospital of Nanjing Medical University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25224292$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkV1LHDEUhkOx1NX6A3pTAr3xZjSfk8mlbF0VhfaiBe_CmZkzGpnNrEnW4r83y9oiglIInJvnyUned4_shCkgIV84O-KMmePEGLdNxbiqRFOLynwgM66krISt9Q6ZMStNZRW_3iV7Kd2x4lhrPpFdoYVQwooZufw5QloCXZwthKQjPuCYKISe3iLETCNkpA8QPbR-9PmR-kBXkD2GnOgfn29pynCDVNP55ffP5OMAY8KD57lPfi9Of83Pq6sfZxfzk6uqU0znqutFw-p2wJ7zwTQdRw4SUXUW6h6FajgHrozV2mBrhhpq1ZXTSzWIVg6N3CeH23tXcbpfY8pu6VOH4wgBp3VyvNaqbmQj-X-gSpsSCtMF_fYKvZvWMZSPbChZAldiQ319ptbtEnu3in4J8dH9TbQAfAt0cUop4vAP4cxtWnPb1lxpzW1ac6Y45pXT-VxSnkKO4Md3TbE1U9kSbjC-ePSb0hMPBafe |
| CitedBy_id | crossref_primary_10_1007_s11739_019_02031_5 crossref_primary_10_1016_j_nephro_2018_10_003 crossref_primary_10_1007_s10157_015_1189_9 crossref_primary_10_1007_s12020_025_04235_6 crossref_primary_10_1080_0886022X_2025_2478487 crossref_primary_10_1007_s11255_018_1995_6 crossref_primary_10_1186_s12933_016_0328_2 crossref_primary_10_3389_fphys_2019_00144 crossref_primary_10_1002_cbin_10997 crossref_primary_10_1038_srep27918 crossref_primary_10_1159_000440984 crossref_primary_10_1007_s11255_019_02076_7 crossref_primary_10_1016_j_jpsychires_2017_08_018 crossref_primary_10_1080_07420528_2018_1486850 crossref_primary_10_3390_toxins10090352 crossref_primary_10_1016_j_jad_2016_11_008 crossref_primary_10_1186_s12882_017_0623_5 crossref_primary_10_1002_ehf2_13331 crossref_primary_10_1080_0886022X_2021_1931318 |
| Cites_doi | 10.2215/CJN.06040710 10.1002/lary.21023 10.1177/147323001103900333 10.1016/j.ehj.2003.09.010 10.1056/NEJMoa041031 10.1001/jama.2011.826 10.1016/j.surg.2005.08.036 10.1046/j.1365-2710.2002.00404.x 10.2215/CJN.03080410 10.1097/01.psy.0000170335.92770.7a 10.1016/j.jamcollsurg.2011.12.046 10.2337/diacare.28.3.668 10.1159/000337571 10.1172/JCI46122 10.1056/NEJMoa0706130 10.1016/j.autneu.2004.08.002 10.2215/CJN.10381012 10.1359/jbmr.2003.18.7.1227 10.1093/ndt/gfh892 10.1359/JBMR.0301264 10.1161/HYPERTENSIONAHA.109.143974 10.1016/j.bbrc.2003.12.102 10.1093/ndt/gfq234 10.1093/ndt/14.6.1480 10.1053/j.ajkd.2013.11.001 10.1681/ASN.2010121224 10.1681/ASN.2005010052 10.1007/s00198-011-1838-0 10.1681/ASN.2004070602 10.1172/JCI36479 10.1161/CIRCULATIONAHA.108.844506 10.1093/ndt/11.supp2.16 10.1093/ndt/18.2.318 10.7326/0003-4819-152-10-201005180-00004 10.1016/j.cmet.2008.10.009 10.1159/000189804 10.1016/j.ijcard.2008.03.039 10.1681/ASN.V1091972 10.1093/oxfordjournals.eurheartj.a014868 10.1210/jc.2013-4050 10.1016/S0272-6386(03)00905-3 |
| ContentType | Journal Article |
| Copyright | International Osteoporosis Foundation and National Osteoporosis Foundation 2014 International Osteoporosis Foundation and National Osteoporosis Foundation 2015 |
| Copyright_xml | – notice: International Osteoporosis Foundation and National Osteoporosis Foundation 2014 – notice: International Osteoporosis Foundation and National Osteoporosis Foundation 2015 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7RV 7TS 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1007/s00198-014-2862-7 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Physical Education Index Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database ProQuest Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China Physical Education Index ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Calcium & Calcified Tissue Abstracts MEDLINE MEDLINE - Academic ProQuest One Academic Middle East (New) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1433-2965 |
| EndPage | 405 |
| ExternalDocumentID | 3549946321 25224292 10_1007_s00198_014_2862_7 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Feature |
| GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 123 199 1N0 1SB 203 28- 29O 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M4Y MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW YLTOR Z45 Z7U Z7W Z82 Z83 Z87 Z8O Z8Q Z8V Z8W Z91 ZMTXR ZOVNA ZXP ~A9 ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION EIHBH PHGZM PHGZT PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7QP 7TS 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c405t-cd2806bfed11f78c1e1a3ee4c9a6de24811a1479557eb7f6a64c64cd34f2b3f83 |
| IEDL.DBID | 8C1 |
| ISICitedReferencesCount | 21 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000347689400040&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0937-941X 1433-2965 |
| IngestDate | Thu Sep 04 15:57:30 EDT 2025 Fri Sep 05 13:00:12 EDT 2025 Tue Nov 04 22:19:09 EST 2025 Thu Apr 03 07:04:08 EDT 2025 Sat Nov 29 05:07:29 EST 2025 Tue Nov 18 22:35:40 EST 2025 Fri Feb 21 02:34:05 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Chronic kidney disease Parathyroidectomy Fibroblast growth factor 23 Heart rate variability Secondary hyperparathyroidism |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c405t-cd2806bfed11f78c1e1a3ee4c9a6de24811a1479557eb7f6a64c64cd34f2b3f83 |
| Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
| PMID | 25224292 |
| PQID | 1643100425 |
| PQPubID | 33762 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_1654683831 proquest_miscellaneous_1645779905 proquest_journals_1643100425 pubmed_primary_25224292 crossref_primary_10_1007_s00198_014_2862_7 crossref_citationtrail_10_1007_s00198_014_2862_7 springer_journals_10_1007_s00198_014_2862_7 |
| PublicationCentury | 2000 |
| PublicationDate | 2015-01-01 |
| PublicationDateYYYYMMDD | 2015-01-01 |
| PublicationDate_xml | – month: 01 year: 2015 text: 2015-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationSubtitle | With other metabolic bone diseases |
| PublicationTitle | Osteoporosis international |
| PublicationTitleAbbrev | Osteoporos Int |
| PublicationTitleAlternate | Osteoporos Int |
| PublicationYear | 2015 |
| Publisher | Springer London Springer Nature B.V |
| Publisher_xml | – name: Springer London – name: Springer Nature B.V |
| References | Gutierrez (CR14) 2009; 119 Gutierrez (CR32) 2008; 359 Kara (CR19) 2010; 120 CR18 Gutierrez (CR33) 2005; 16 Evenepoel (CR40) 2005; 20 Schroeder (CR23) 2005; 28 Faul (CR38) 2011; 121 Naranda, Ekart, Pecovnik-Balon (CR41) 2011; 39 Kendrick (CR12) 2011; 22 Sarafidis (CR27) 2012; 120 Polak (CR31) 2004; 115 Chan (CR26) 2010; 5 Nasri, Baradaran (CR30) 2004; 105 Cunningham, Locatelli, Rodriguez (CR4) 2011; 6 Go (CR1) 2004; 351 Sinha, Light, Agarwal (CR17) 2010; 55 Roumelioti (CR21) 2010; 25 Sharma (CR44) 2012; 214 Richards (CR45) 2006; 139 Collins (CR2) 2014; 63 CR3 Isakova (CR11) 2011; 305 Parker (CR13) 2010; 152 Gianaros (CR35) 2005; 67 Fukuta (CR20) 2003; 18 Weber (CR24) 2003; 18 Cheung, Ong, Wong (CR39) 2009; 135 Saleh (CR37) 2003; 24 Shimada (CR8) 2004; 314 Routledge, Chowdhary, Townend (CR28) 2002; 27 Ben-Dov (CR9) 2007; 117 Hayano (CR22) 1999; 14 Kestenbaum (CR29) 2005; 16 Longenecker (CR36) 2009; 18 CR25 Wang (CR34) 2008; 8 Quarles (CR7) 2008; 118 Rubinger (CR5) 1999; 10 CR43 Shimada (CR10) 2004; 19 Charra (CR16) 1996; 11 Chow (CR42) 2003; 16 Zhang (CR6) 2013; 8 Desjardins (CR15) 2012; 23 J Kendrick (2862_CR12) 2011; 22 TJ Weber (2862_CR24) 2003; 18 CT Chan (2862_CR26) 2010; 5 AD Sinha (2862_CR17) 2010; 55 T Shimada (2862_CR8) 2004; 314 OM Gutierrez (2862_CR32) 2008; 359 C Faul (2862_CR38) 2011; 121 J Cunningham (2862_CR4) 2011; 6 2862_CR3 O Gutierrez (2862_CR33) 2005; 16 AS Go (2862_CR1) 2004; 351 M Kara (2862_CR19) 2010; 120 2862_CR25 BM Cheung (2862_CR39) 2009; 135 2862_CR43 H Nasri (2862_CR30) 2004; 105 KM Chow (2862_CR42) 2003; 16 B Charra (2862_CR16) 1996; 11 J Naranda (2862_CR41) 2011; 39 T Isakova (2862_CR11) 2011; 305 HC Routledge (2862_CR28) 2002; 27 PJ Gianaros (2862_CR35) 2005; 67 G Polak (2862_CR31) 2004; 115 JC Longenecker (2862_CR36) 2009; 18 P Evenepoel (2862_CR40) 2005; 20 D Rubinger (2862_CR5) 1999; 10 IZ Ben-Dov (2862_CR9) 2007; 117 LD Quarles (2862_CR7) 2008; 118 BD Parker (2862_CR13) 2010; 152 PA Sarafidis (2862_CR27) 2012; 120 J Hayano (2862_CR22) 1999; 14 J Zhang (2862_CR6) 2013; 8 2862_CR18 ME Roumelioti (2862_CR21) 2010; 25 N Wang (2862_CR34) 2008; 8 H Fukuta (2862_CR20) 2003; 18 AJ Collins (2862_CR2) 2014; 63 T Shimada (2862_CR10) 2004; 19 B Kestenbaum (2862_CR29) 2005; 16 ML Richards (2862_CR45) 2006; 139 EB Schroeder (2862_CR23) 2005; 28 FN Saleh (2862_CR37) 2003; 24 J Sharma (2862_CR44) 2012; 214 OM Gutierrez (2862_CR14) 2009; 119 L Desjardins (2862_CR15) 2012; 23 18687639 - N Engl J Med. 2008 Aug 7;359(6):584-92 15507410 - Auton Neurosci. 2004 Sep 30;115(1-2):94-8 19644521 - Kidney Int Suppl. 2009 Aug;(113):S1-130 19033649 - J Clin Invest. 2008 Dec;118(12):3820-8 19204425 - Med Princ Pract. 2009;18(2):85-92 21819732 - J Int Med Res. 2011;39(3):978-87 8737210 - Eur Heart J. 1996 Mar;17(3):354-81 15735206 - Diabetes Care. 2005 Mar;28(3):668-74 22463880 - J Am Coll Surg. 2012 Apr;214(4):400-7; discussion 407-8 11975691 - J Clin Pharm Ther. 2002 Apr;27(2):85-92 24476081 - J Clin Endocrinol Metab. 2014 Apr;99(4):E652-8 15658577 - Bratisl Lek Listy. 2004;105(10-11):368-73 24360288 - Am J Kidney Dis. 2014 Jan;63(1 Suppl):A7 10383012 - Nephrol Dial Transplant. 1999 Jun;14(6):1480-8 8803988 - Nephrol Dial Transplant. 1996;11 Suppl 2:16-9 23660181 - Clin J Am Soc Nephrol. 2013 Aug;8(8):1378-87 12543887 - Nephrol Dial Transplant. 2003 Feb;18(2):318-25 21903574 - J Am Soc Nephrol. 2011 Oct;22(10):1913-22 15919696 - Nephrol Dial Transplant. 2005 Aug;20(8):1714-20 15385656 - N Engl J Med. 2004 Sep 23;351(13):1296-305 15615819 - J Am Soc Nephrol. 2005 Feb;16(2):520-8 21985788 - J Clin Invest. 2011 Nov;121(11):4393-408 20616163 - Clin J Am Soc Nephrol. 2010 Oct;5(10):1821-7 14520607 - Am J Kidney Dis. 2003 Oct;42(4 Suppl 3):S1-201 21454719 - Clin J Am Soc Nephrol. 2011 Apr;6(4):913-21 18572267 - Int J Cardiol. 2009 Jun 26;135(2):156-61 19041764 - Cell Metab. 2008 Dec;8(6):482-91 20641075 - Laryngoscope. 2010 Aug;120(8):1538-44 14733920 - Biochem Biophys Res Commun. 2004 Feb 6;314(2):409-14 21673295 - JAMA. 2011 Jun 15;305(23):2432-9 16455325 - Surgery. 2006 Feb;139(2):174-80 20479029 - Ann Intern Med. 2010 May 18;152(10):640-8 15917335 - J Am Soc Nephrol. 2005 Jul;16(7):2205-15 22678150 - Nephron Clin Pract. 2012;120(3):c147-55 19414634 - Circulation. 2009 May 19;119(19):2545-52 12854832 - J Bone Miner Res. 2003 Jul;18(7):1227-34 15040831 - J Bone Miner Res. 2004 Mar;19(3):429-35 20466675 - Nephrol Dial Transplant. 2010 Nov;25(11):3733-41 16046367 - Psychosom Med. 2005 Jul-Aug;67(4):553-60 17992255 - J Clin Invest. 2007 Dec;117(12):4003-8 10477150 - J Am Soc Nephrol. 1999 Sep;10(9):1972-81 20038754 - Hypertension. 2010 Feb;55(2):305-11 14613742 - Eur Heart J. 2003 Nov;24(22):2054-60 22109743 - Osteoporos Int. 2012 Jul;23(7):2017-25 14736016 - J Nephrol. 2003 Nov-Dec;16(6):878-85 |
| References_xml | – volume: 6 start-page: 913 issue: 4 year: 2011 end-page: 921 ident: CR4 article-title: Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.06040710 – volume: 120 start-page: 1538 issue: 8 year: 2010 end-page: 1544 ident: CR19 article-title: Evaluation of intraoperative parathormone measurement for predicting successful surgery in patients undergoing subtotal/total parathyroidectomy due to secondary hyperparathyroidism publication-title: Laryngoscope doi: 10.1002/lary.21023 – volume: 39 start-page: 978 issue: 3 year: 2011 end-page: 987 ident: CR41 article-title: Total parathyroidectomy with forearm autotransplantation as the treatment of choice for secondary hyperparathyroidism publication-title: J Int Med Res doi: 10.1177/147323001103900333 – volume: 24 start-page: 2054 issue: 22 year: 2003 end-page: 2060 ident: CR37 article-title: Parathyroid hormone and left ventricular hypertrophy publication-title: Eur Heart J doi: 10.1016/j.ehj.2003.09.010 – ident: CR18 – ident: CR43 – volume: 351 start-page: 1296 issue: 13 year: 2004 end-page: 1305 ident: CR1 article-title: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization publication-title: N Engl J Med doi: 10.1056/NEJMoa041031 – volume: 305 start-page: 2432 issue: 23 year: 2011 end-page: 2439 ident: CR11 article-title: Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease publication-title: JAMA doi: 10.1001/jama.2011.826 – volume: 105 start-page: 368 issue: 10–11 year: 2004 end-page: 373 ident: CR30 article-title: Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis publication-title: Bratisl Lek Listy – volume: 139 start-page: 174 issue: 2 year: 2006 end-page: 180 ident: CR45 article-title: Parathyroidectomy in secondary hyperparathyroidism: is there an optimal operative management? publication-title: Surgery doi: 10.1016/j.surg.2005.08.036 – volume: 27 start-page: 85 issue: 2 year: 2002 end-page: 92 ident: CR28 article-title: Heart rate variability—a therapeutic target? publication-title: J Clin Pharm Ther doi: 10.1046/j.1365-2710.2002.00404.x – volume: 16 start-page: 878 issue: 6 year: 2003 end-page: 885 ident: CR42 article-title: Improved health-related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy publication-title: J Nephrol – volume: 10 start-page: 1972 issue: 9 year: 1999 end-page: 1981 ident: CR5 article-title: Heart rate variability during chronic hemodialysis and after renal transplantation: studies in patients without and with systemic amyloidosis publication-title: J Am Soc Nephrol – volume: 5 start-page: 1821 issue: 10 year: 2010 end-page: 1827 ident: CR26 article-title: Determinants of cardiac autonomic dysfunction in ESRD publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.03080410 – volume: 67 start-page: 553 issue: 4 year: 2005 end-page: 560 ident: CR35 article-title: A greater reduction in high-frequency heart rate variability to a psychological stressor is associated with subclinical coronary and aortic calcification in postmenopausal women publication-title: Psychosom Med doi: 10.1097/01.psy.0000170335.92770.7a – volume: 214 start-page: 400 issue: 4 year: 2012 end-page: 407 ident: CR44 article-title: Improved long-term survival of dialysis patients after near-total parathyroidectomy publication-title: J Am Coll Surg doi: 10.1016/j.jamcollsurg.2011.12.046 – volume: 28 start-page: 668 issue: 3 year: 2005 end-page: 674 ident: CR23 article-title: Diabetes, glucose, insulin, and heart rate variability: the atherosclerosis risk in communities (ARIC) study publication-title: Diabetes Care doi: 10.2337/diacare.28.3.668 – volume: 120 start-page: c147 issue: 3 year: 2012 end-page: c155 ident: CR27 article-title: Prevalence, patterns of treatment, and control of hypertension in predialysis patients with chronic kidney disease publication-title: Nephron Clin Pract doi: 10.1159/000337571 – volume: 121 start-page: 4393 issue: 11 year: 2011 end-page: 4408 ident: CR38 article-title: FGF23 induces left ventricular hypertrophy publication-title: J Clin Invest doi: 10.1172/JCI46122 – volume: 359 start-page: 584 issue: 6 year: 2008 end-page: 592 ident: CR32 article-title: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis publication-title: N Engl J Med doi: 10.1056/NEJMoa0706130 – volume: 115 start-page: 94 issue: 1–2 year: 2004 end-page: 98 ident: CR31 article-title: Effect of parathormone on heart rate variability in hemodialysis patients publication-title: Auton Neurosci doi: 10.1016/j.autneu.2004.08.002 – ident: CR25 – volume: 8 start-page: 1378 issue: 8 year: 2013 end-page: 1387 ident: CR6 article-title: Parathyroidectomy and heart rate variability in patients with stage 5 CKD publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.10381012 – volume: 18 start-page: 1227 issue: 7 year: 2003 end-page: 1234 ident: CR24 article-title: Serum FGF23 levels in normal and disordered phosphorus homeostasis publication-title: J Bone Miner Res doi: 10.1359/jbmr.2003.18.7.1227 – volume: 20 start-page: 1714 issue: 8 year: 2005 end-page: 1720 ident: CR40 article-title: Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfh892 – volume: 19 start-page: 429 issue: 3 year: 2004 end-page: 435 ident: CR10 article-title: FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis publication-title: J Bone Miner Res doi: 10.1359/JBMR.0301264 – volume: 55 start-page: 305 issue: 2 year: 2010 end-page: 311 ident: CR17 article-title: Relative plasma volume monitoring during hemodialysis AIDS the assessment of dry weight publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.109.143974 – ident: CR3 – volume: 314 start-page: 409 issue: 2 year: 2004 end-page: 414 ident: CR8 article-title: FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2003.12.102 – volume: 25 start-page: 3733 issue: 11 year: 2010 end-page: 3741 ident: CR21 article-title: Abnormal nocturnal heart rate variability response among chronic kidney disease and dialysis patients during wakefulness and sleep publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfq234 – volume: 14 start-page: 1480 issue: 6 year: 1999 end-page: 1488 ident: CR22 article-title: Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/14.6.1480 – volume: 63 start-page: A7 issue: 1 Suppl year: 2014 ident: CR2 article-title: US renal data system 2013 annual data report publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2013.11.001 – volume: 22 start-page: 1913 issue: 10 year: 2011 end-page: 1922 ident: CR12 article-title: FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2010121224 – volume: 16 start-page: 2205 issue: 7 year: 2005 end-page: 2215 ident: CR33 article-title: Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2005010052 – volume: 117 start-page: 4003 issue: 12 year: 2007 end-page: 4008 ident: CR9 article-title: The parathyroid is a target organ for FGF23 in rats publication-title: J Clin Invest – volume: 23 start-page: 2017 issue: 7 year: 2012 end-page: 2025 ident: CR15 article-title: FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages publication-title: Osteoporos Int doi: 10.1007/s00198-011-1838-0 – volume: 16 start-page: 520 issue: 2 year: 2005 end-page: 528 ident: CR29 article-title: Serum phosphate levels and mortality risk among people with chronic kidney disease publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2004070602 – volume: 118 start-page: 3820 issue: 12 year: 2008 end-page: 3828 ident: CR7 article-title: Endocrine functions of bone in mineral metabolism regulation publication-title: J Clin Invest doi: 10.1172/JCI36479 – volume: 119 start-page: 2545 issue: 19 year: 2009 end-page: 2552 ident: CR14 article-title: Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.844506 – volume: 11 start-page: 16 issue: Suppl 2 year: 1996 end-page: 19 ident: CR16 article-title: Clinical assessment of dry weight publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/11.supp2.16 – volume: 18 start-page: 318 issue: 2 year: 2003 end-page: 325 ident: CR20 article-title: Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/18.2.318 – volume: 152 start-page: 640 issue: 10 year: 2010 end-page: 648 ident: CR13 article-title: The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the heart and soul study publication-title: Ann Intern Med doi: 10.7326/0003-4819-152-10-201005180-00004 – volume: 8 start-page: 482 issue: 6 year: 2008 end-page: 491 ident: CR34 article-title: Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1 publication-title: Cell Metab doi: 10.1016/j.cmet.2008.10.009 – volume: 18 start-page: 85 issue: 2 year: 2009 end-page: 92 ident: CR36 article-title: Association of low heart rate variability with atherosclerotic cardiovascular disease in hemodialysis patients publication-title: Med Princ Pract doi: 10.1159/000189804 – volume: 135 start-page: 156 issue: 2 year: 2009 end-page: 161 ident: CR39 article-title: Elevated serum alkaline phosphatase and peripheral arterial disease in the United States National Health and Nutrition Examination Survey 1999–2004 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2008.03.039 – volume: 139 start-page: 174 issue: 2 year: 2006 ident: 2862_CR45 publication-title: Surgery doi: 10.1016/j.surg.2005.08.036 – volume: 314 start-page: 409 issue: 2 year: 2004 ident: 2862_CR8 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2003.12.102 – volume: 5 start-page: 1821 issue: 10 year: 2010 ident: 2862_CR26 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.03080410 – volume: 115 start-page: 94 issue: 1–2 year: 2004 ident: 2862_CR31 publication-title: Auton Neurosci doi: 10.1016/j.autneu.2004.08.002 – volume: 305 start-page: 2432 issue: 23 year: 2011 ident: 2862_CR11 publication-title: JAMA doi: 10.1001/jama.2011.826 – volume: 117 start-page: 4003 issue: 12 year: 2007 ident: 2862_CR9 publication-title: J Clin Invest – volume: 359 start-page: 584 issue: 6 year: 2008 ident: 2862_CR32 publication-title: N Engl J Med doi: 10.1056/NEJMoa0706130 – volume: 39 start-page: 978 issue: 3 year: 2011 ident: 2862_CR41 publication-title: J Int Med Res doi: 10.1177/147323001103900333 – volume: 25 start-page: 3733 issue: 11 year: 2010 ident: 2862_CR21 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfq234 – volume: 63 start-page: A7 issue: 1 Suppl year: 2014 ident: 2862_CR2 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2013.11.001 – volume: 120 start-page: c147 issue: 3 year: 2012 ident: 2862_CR27 publication-title: Nephron Clin Pract doi: 10.1159/000337571 – volume: 24 start-page: 2054 issue: 22 year: 2003 ident: 2862_CR37 publication-title: Eur Heart J doi: 10.1016/j.ehj.2003.09.010 – volume: 8 start-page: 1378 issue: 8 year: 2013 ident: 2862_CR6 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.10381012 – volume: 18 start-page: 1227 issue: 7 year: 2003 ident: 2862_CR24 publication-title: J Bone Miner Res doi: 10.1359/jbmr.2003.18.7.1227 – volume: 27 start-page: 85 issue: 2 year: 2002 ident: 2862_CR28 publication-title: J Clin Pharm Ther doi: 10.1046/j.1365-2710.2002.00404.x – volume: 10 start-page: 1972 issue: 9 year: 1999 ident: 2862_CR5 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V1091972 – volume: 20 start-page: 1714 issue: 8 year: 2005 ident: 2862_CR40 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfh892 – volume: 16 start-page: 2205 issue: 7 year: 2005 ident: 2862_CR33 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2005010052 – volume: 6 start-page: 913 issue: 4 year: 2011 ident: 2862_CR4 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.06040710 – volume: 152 start-page: 640 issue: 10 year: 2010 ident: 2862_CR13 publication-title: Ann Intern Med doi: 10.7326/0003-4819-152-10-201005180-00004 – volume: 135 start-page: 156 issue: 2 year: 2009 ident: 2862_CR39 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2008.03.039 – volume: 23 start-page: 2017 issue: 7 year: 2012 ident: 2862_CR15 publication-title: Osteoporos Int doi: 10.1007/s00198-011-1838-0 – volume: 119 start-page: 2545 issue: 19 year: 2009 ident: 2862_CR14 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.844506 – volume: 11 start-page: 16 issue: Suppl 2 year: 1996 ident: 2862_CR16 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/11.supp2.16 – ident: 2862_CR25 doi: 10.1093/oxfordjournals.eurheartj.a014868 – volume: 55 start-page: 305 issue: 2 year: 2010 ident: 2862_CR17 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.109.143974 – volume: 67 start-page: 553 issue: 4 year: 2005 ident: 2862_CR35 publication-title: Psychosom Med doi: 10.1097/01.psy.0000170335.92770.7a – volume: 16 start-page: 520 issue: 2 year: 2005 ident: 2862_CR29 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2004070602 – volume: 19 start-page: 429 issue: 3 year: 2004 ident: 2862_CR10 publication-title: J Bone Miner Res doi: 10.1359/JBMR.0301264 – volume: 22 start-page: 1913 issue: 10 year: 2011 ident: 2862_CR12 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2010121224 – volume: 18 start-page: 318 issue: 2 year: 2003 ident: 2862_CR20 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/18.2.318 – volume: 14 start-page: 1480 issue: 6 year: 1999 ident: 2862_CR22 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/14.6.1480 – volume: 8 start-page: 482 issue: 6 year: 2008 ident: 2862_CR34 publication-title: Cell Metab doi: 10.1016/j.cmet.2008.10.009 – volume: 121 start-page: 4393 issue: 11 year: 2011 ident: 2862_CR38 publication-title: J Clin Invest doi: 10.1172/JCI46122 – volume: 214 start-page: 400 issue: 4 year: 2012 ident: 2862_CR44 publication-title: J Am Coll Surg doi: 10.1016/j.jamcollsurg.2011.12.046 – volume: 28 start-page: 668 issue: 3 year: 2005 ident: 2862_CR23 publication-title: Diabetes Care doi: 10.2337/diacare.28.3.668 – ident: 2862_CR43 doi: 10.1210/jc.2013-4050 – ident: 2862_CR3 – volume: 105 start-page: 368 issue: 10–11 year: 2004 ident: 2862_CR30 publication-title: Bratisl Lek Listy – volume: 18 start-page: 85 issue: 2 year: 2009 ident: 2862_CR36 publication-title: Med Princ Pract doi: 10.1159/000189804 – volume: 120 start-page: 1538 issue: 8 year: 2010 ident: 2862_CR19 publication-title: Laryngoscope doi: 10.1002/lary.21023 – volume: 351 start-page: 1296 issue: 13 year: 2004 ident: 2862_CR1 publication-title: N Engl J Med doi: 10.1056/NEJMoa041031 – ident: 2862_CR18 doi: 10.1016/S0272-6386(03)00905-3 – volume: 118 start-page: 3820 issue: 12 year: 2008 ident: 2862_CR7 publication-title: J Clin Invest doi: 10.1172/JCI36479 – volume: 16 start-page: 878 issue: 6 year: 2003 ident: 2862_CR42 publication-title: J Nephrol – reference: 14520607 - Am J Kidney Dis. 2003 Oct;42(4 Suppl 3):S1-201 – reference: 14733920 - Biochem Biophys Res Commun. 2004 Feb 6;314(2):409-14 – reference: 20641075 - Laryngoscope. 2010 Aug;120(8):1538-44 – reference: 24360288 - Am J Kidney Dis. 2014 Jan;63(1 Suppl):A7 – reference: 21819732 - J Int Med Res. 2011;39(3):978-87 – reference: 15919696 - Nephrol Dial Transplant. 2005 Aug;20(8):1714-20 – reference: 19041764 - Cell Metab. 2008 Dec;8(6):482-91 – reference: 8737210 - Eur Heart J. 1996 Mar;17(3):354-81 – reference: 23660181 - Clin J Am Soc Nephrol. 2013 Aug;8(8):1378-87 – reference: 18572267 - Int J Cardiol. 2009 Jun 26;135(2):156-61 – reference: 11975691 - J Clin Pharm Ther. 2002 Apr;27(2):85-92 – reference: 17992255 - J Clin Invest. 2007 Dec;117(12):4003-8 – reference: 16046367 - Psychosom Med. 2005 Jul-Aug;67(4):553-60 – reference: 15615819 - J Am Soc Nephrol. 2005 Feb;16(2):520-8 – reference: 19414634 - Circulation. 2009 May 19;119(19):2545-52 – reference: 12854832 - J Bone Miner Res. 2003 Jul;18(7):1227-34 – reference: 8803988 - Nephrol Dial Transplant. 1996;11 Suppl 2:16-9 – reference: 14613742 - Eur Heart J. 2003 Nov;24(22):2054-60 – reference: 12543887 - Nephrol Dial Transplant. 2003 Feb;18(2):318-25 – reference: 22463880 - J Am Coll Surg. 2012 Apr;214(4):400-7; discussion 407-8 – reference: 15385656 - N Engl J Med. 2004 Sep 23;351(13):1296-305 – reference: 21673295 - JAMA. 2011 Jun 15;305(23):2432-9 – reference: 18687639 - N Engl J Med. 2008 Aug 7;359(6):584-92 – reference: 21903574 - J Am Soc Nephrol. 2011 Oct;22(10):1913-22 – reference: 14736016 - J Nephrol. 2003 Nov-Dec;16(6):878-85 – reference: 19033649 - J Clin Invest. 2008 Dec;118(12):3820-8 – reference: 15507410 - Auton Neurosci. 2004 Sep 30;115(1-2):94-8 – reference: 19644521 - Kidney Int Suppl. 2009 Aug;(113):S1-130 – reference: 15040831 - J Bone Miner Res. 2004 Mar;19(3):429-35 – reference: 15917335 - J Am Soc Nephrol. 2005 Jul;16(7):2205-15 – reference: 16455325 - Surgery. 2006 Feb;139(2):174-80 – reference: 19204425 - Med Princ Pract. 2009;18(2):85-92 – reference: 21454719 - Clin J Am Soc Nephrol. 2011 Apr;6(4):913-21 – reference: 10477150 - J Am Soc Nephrol. 1999 Sep;10(9):1972-81 – reference: 21985788 - J Clin Invest. 2011 Nov;121(11):4393-408 – reference: 20466675 - Nephrol Dial Transplant. 2010 Nov;25(11):3733-41 – reference: 15735206 - Diabetes Care. 2005 Mar;28(3):668-74 – reference: 24476081 - J Clin Endocrinol Metab. 2014 Apr;99(4):E652-8 – reference: 10383012 - Nephrol Dial Transplant. 1999 Jun;14(6):1480-8 – reference: 20616163 - Clin J Am Soc Nephrol. 2010 Oct;5(10):1821-7 – reference: 20038754 - Hypertension. 2010 Feb;55(2):305-11 – reference: 22678150 - Nephron Clin Pract. 2012;120(3):c147-55 – reference: 15658577 - Bratisl Lek Listy. 2004;105(10-11):368-73 – reference: 22109743 - Osteoporos Int. 2012 Jul;23(7):2017-25 – reference: 20479029 - Ann Intern Med. 2010 May 18;152(10):640-8 |
| SSID | ssj0007997 |
| Score | 2.259434 |
| Snippet | Summary
Fibroblast growth factor 23(FGF23) is a bone-derived hormone which regulates mineral homeostasis but may also have a role in cardiovascular disease.... Fibroblast growth factor 23(FGF23) is a bone-derived hormone which regulates mineral homeostasis but may also have a role in cardiovascular disease. Here, we... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 395 |
| SubjectTerms | Adult Cardiovascular Diseases - etiology Case-Control Studies Cross-Sectional Studies Electrocardiography, Ambulatory - methods Endocrine system Endocrinology Female Fibroblast Growth Factors - blood Follow-Up Studies Heart rate Heart Rate - physiology Humans Hyperparathyroidism, Secondary - blood Hyperparathyroidism, Secondary - etiology Hyperparathyroidism, Secondary - surgery Kidney diseases Male Medicine Medicine & Public Health Middle Aged Original Article Orthopedics Parathyroidectomy Plasma Renal Insufficiency, Chronic - blood Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - physiopathology Rheumatology |
| SummonAdditionalLinks | – databaseName: Springer LINK dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8UwEB7cEC_uS92I4EkJmCZp0qOoT8EFcePdSpqmImgV-xT89066obiAQm-dlmEymXyTL5kB2Mx8WmGEpS7NUyoYxsFUxYqamPEcAYh1tupacqLOznS_H58397jL9rR7S0lWkbq77ObRiD94JWiIMJyqYRjF1U772XhxedOFXxVXHVUwU1c0FqzfUpnf_eLzYvQFYX5hR6tFpzf1L3WnYbLBmGS3dooZGHLFLIyfNiz6HByfI2R-MKR32As5uffHhkpiioz47tYD4otHkFfMoesS3m_kriBN-dWS-H1bgojy1hFJ9o735-G6d3C1d0SbpgrUIjYbUJt5LjXNXcZYrrRljhnunLCxiTIXCs2YYULFUiqXqjwykbD4ZFzkYcpzzRdgpHgs3BIQLVXOMhlhzqOFjEMTSZ5xZVObRlxpE8BOa93ENhXHfeOL-6SrlVwZKUEjJd5IiQpgq_vkqS638ZvwajtkSTPzygTTP89ZYCgKYKN7jXPGEyGmcI8vlYxU6Cc7v8pIEWnM31kAi7U7dBqFCFp9m68Attux_6DAT-ou_0l6BSYQm8l6t2cVRgbPL24Nxuzr4K58Xq9c_h3gRPbp priority: 102 providerName: Springer Nature |
| Title | Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD |
| URI | https://link.springer.com/article/10.1007/s00198-014-2862-7 https://www.ncbi.nlm.nih.gov/pubmed/25224292 https://www.proquest.com/docview/1643100425 https://www.proquest.com/docview/1645779905 https://www.proquest.com/docview/1654683831 |
| Volume | 26 |
| WOSCitedRecordID | wos000347689400040&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1433-2965 dateEnd: 20161231 omitProxy: false ssIdentifier: ssj0007997 issn: 0937-941X databaseCode: 7X7 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1433-2965 dateEnd: 20161231 omitProxy: false ssIdentifier: ssj0007997 issn: 0937-941X databaseCode: 7RV dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1433-2965 dateEnd: 20161231 omitProxy: false ssIdentifier: ssj0007997 issn: 0937-941X databaseCode: BENPR dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1433-2965 dateEnd: 20161231 omitProxy: false ssIdentifier: ssj0007997 issn: 0937-941X databaseCode: 8C1 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVAVX databaseName: Springer LINK customDbUrl: eissn: 1433-2965 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007997 issn: 0937-941X databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEB-8OxFf_P6onksEn5Tgpkma9El0vVU4XZZVj30raZLKwdk9r3sH_vdO0nRPOdwXoQRKUxg6M8lvZtL5AbxwIawwwlJfNzUVDNfBWpWKmpLxBgGI9TaylnxSs5leLst5Srh16VjlsCbGhdqtbMiRv0ZYH3LRaGJvTn_SwBoVqquJQmMH9lg-FsEx9eTyiIcqI7kKBu2KloIth6rmODYRZeHnMiZojqCeqr_3pStg80qhNO4_09v_K_kduJWQJ3nbm8pduObbe3Djc6qt34fDOQLpH4ZMP0xzTk7CYaKOmNaRwHm9JqGlBLnAyLpv7P2LHLckNWXtSMjmEsSZ3z2RZHL4_gF8mx58nXykiWqBWkRsa2pdqLDWjXeMNUpb5pnh3gtbmsL5XGjGDBOqlFL5WjWFKYTFy3HR5DVvNH8Iu-2q9Y-BaKka5mSBkZAWssxNIbnjyta2LrjSJoPx8KErm_qQBzqMk2rTQTnqpkLdVEE3lcrg5eaV074Jx7bJ-4MaquSPXXWpgwyebx6jJ4XyiGn96jzOkQpNZrx1jhSFxqieZfCot4yNRDlC2UD-lcGrwVT-EOBf4j7ZLu5TuIkQTfZJn33YXZ-d-2dw3V6sj7uzEeyoxVEYlyqOehQdYAR77w5m8wXeLb4c_QaECgaF |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgigX3o9AASPBBWSxju3YOSCEtiytdrvqoUh7C47toEpttjTbov4pfiNjJ9mCKvbWA1JucSIn83n8zcMzAK9dMCuMsNSXVUkFQz1YqlxRkzNeIQGx3sauJRM1nerZLN9bg1_9WZiQVtnrxKio3dwGH_l7pPXBF40Q-3j8g4auUSG62rfQaGEx9uc_0WRrPuxsoXzfpOno8_5wm3ZdBahFcrKg1oVgYll5x1iltGWeGe69sLnJnE-FZswwoXIplS9VlZlMWLwcF1Va8kpzfO81uB4q2QVjTw8vUkpUHpu5DHDLp7lgsz6KOohFS1k4zMYETdGIoOrvffASub0UmI373ejO__an7sLtjlmTT-1SuAdrvr4PN3e73IEHMN5DQ-HIkNGXUcrJYUiWaoipHQk9vRcklMwgZwbXY0wXPicHNemKzjYkeKsJ8ujvnkgyHG89hK9X8imPYL2e1_4JEC1VxZzM0NLTQuapySR3XNnSlhlX2iQw6AVb2K7Oemj3cVgsK0RHLBSIhSJgoVAJvF0-ctwWGVk1eLMXe9Hpm6a4kHkCr5a3UVOE8I-p_fw0jpEKITpYOUaKTHPNWQKPWyQuZ5QiVQ_NzRJ410Pzjwn8a7pPV0_3JWxs7-9OisnOdPwMbiEdla2DaxPWFyen_jncsGeLg-bkRVxqBL5dNWJ_A0R8X1g |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgqpeKM82tICR4AKyuo7t2DkghHYJVFtWewBpb8FxbFSpzZZmW9S_xq9jnMcWVLG3HpByixNN4s_jeXk-gJdlcCuMsNQVvqCCoR4sVKqoSRn3aIBYZxvWkkM1mejZLJ2uwa_-LEwoq-x1YqOoy7kNMfJ9NOtDLBohtu-7sojpKHt3-oMGBqmQae3pNFqIjN3lT3Tf6rcHI5zrV3Gcffgy_EQ7hgFq0VBZUFuGxGLhXcmYV9oyxwx3TtjUJKWLhWbMMKFSKZUrlE9MIixeJRc-LrjXHN97C24rjigOp9SHV-UlKm2IXQa4_dNUsFmfUR00DUxZONjGBI3RoaDq7z3xmqF7LUnb7H3Z1v_81-7B3c7iJu_bJXIf1lz1ADY-dzUFD2E8RQfixJDsYxZzchyKqGpiqpIEru8FCa00yIXBddqUEV-So4p0zWhrEqLYBO3r745IMhyPHsHXG_mUx7BezSu3A0RL5VkpE_QAtZBpbBLJS65sYYuEK20iGPSTnNuu_3qgATnOl52jG1zkiIs84CJXEbxePnLaNh9ZNXivh0De6aE6v5r_CF4sb6MGCWkhU7n5eTNGKoTrYOUYKRLNNWcRbLeoXEoUowkfSM8ieNPD9A8B_iXuk9XiPocNBGp-eDAZ78ImWqmyjXvtwfri7Nw9hTv2YnFUnz1rVh2BbzcN2N9Gomgd |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+FGF23+levels+and+heart+rate+variability+in+patients+with+stage+5+CKD&rft.jtitle=Osteoporosis+international&rft.au=Zhang%2C+L-N&rft.au=Yang%2C+G&rft.au=Cheng%2C+C&rft.au=Shen%2C+C&rft.date=2015-01-01&rft.issn=1433-2965&rft.eissn=1433-2965&rft.volume=26&rft.issue=1&rft.spage=395&rft_id=info:doi/10.1007%2Fs00198-014-2862-7&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0937-941X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0937-941X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0937-941X&client=summon |